UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026045
Receipt number R000029932
Scientific Title Femoral triangle block versus femoral nerve block for attainment of early discharge criteria after total knee arthroplasty
Date of disclosure of the study information 2017/02/08
Last modified on 2020/11/03 13:01:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Femoral triangle block versus femoral nerve block for attainment of early discharge criteria after total knee arthroplasty

Acronym

Femoral triangle block versus femoral nerve block for attainment of early discharge criteria after total knee arthroplasty

Scientific Title

Femoral triangle block versus femoral nerve block for attainment of early discharge criteria after total knee arthroplasty

Scientific Title:Acronym

Femoral triangle block versus femoral nerve block for attainment of early discharge criteria after total knee arthroplasty

Region

Japan


Condition

Condition

patients receiving total knee arthroplasty for knee osteoarthritis

Classification by specialty

Orthopedics Anesthesiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim is to clarify that femoral trianle block was noninferior to femoral nerve block for the attainment time of early discharge criteria after total knee arthroplasty

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Attainment time of early discharge criteria

Key secondary outcomes

Postoperative pain score (VRS)(Postoperative 1 hour, time point per 8 hours till postoperative 72 hours)
Postoperative motor function (1, 24, 72 hours)
Postoperative rehabilitation score and muscle power(24, 48, 72 hours)
Consumption of postoperative additional analgesics(72 hours)
Complication(72 hours)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Group FNB: preoperative femoral nerve block with 0.25% levobupivacaine

Interventions/Control_2

Group FTB: preoperative femoral triangle nerve block with 0.25% levobupivacaine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Patients scheduled unilateral total knee arthroplasty at Daiyukai General Hospital
2.Adults (>=20 years) with American Society of Anaesthesiologists Physical Status Classification I-III
3.Participants were scheduled for primary unilateral TKA for osteoarthritis
4.Written informed consent is provided

Key exclusion criteria

1.Inability to communicate lucidly
2.Bilateral TKA
3.revision knee arthroplasty
4.Under 20 years old
5.Allergy to any of the drugs used in this study
6.ASA-PS > III
7.Chronic opioid use
8.Diabetes mellitus with sensory disorders
9.Neurological disability
10.Infections around femoral crease
11.Platelet < 5.0 * 10^4 /mcl
12.Pregnancy, possibility of pregnancy, or breast-feeding women
13.Contraindications to peripheral nerve blocks

Target sample size

160


Research contact person

Name of lead principal investigator

1st name Norihiro
Middle name
Last name Sakai

Organization

Daiyukai General Hospital

Division name

Dep. Anaesthesiplogy

Zip code

491-8551

Address

1-9-9, Sakura, Ichinomiya, Aichi, Japan

TEL

+81-586-72-1211

Email

sakayline@anes.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Norihiro
Middle name
Last name Sakai

Organization

Daiyukai General Hospital

Division name

Dep. Anaesthesiology

Zip code

491-8551

Address

1-9-9, Sakura, Ichinomiya, Aichi, Japan

TEL

+81-586-72-1211

Homepage URL

http://www.wb.commufa.jp/dykmasui/

Email

sakayline@anes.med.osaka-u.ac.jp


Sponsor or person

Institute

Daiyukai General Hospital
Dep. Anaesthesiology

Institute

Department

Personal name



Funding Source

Organization

Daiyukai General Hospital
Dep. Anaesthesiology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institution of Review Board of Daiyukai general Hospital

Address

1-9-9, Sakura, Ichinomiya, Aichi, Japan

Tel

+81-586-72-1211

Email

extensor2@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

総合大雄会病院


Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 08 Day


Related information

URL releasing protocol

http://u0u1.net/wWx3

Publication of results

Unpublished


Result

URL related to results and publications

http://u0u1.net/x3Gv

Number of participants that the trial has enrolled

179

Results

The postoperative discharge criteria were attained after (mean/SD) 63.3/20.6 h in the FNB group and 60.6/16.5 h in the pACB group. The mean difference between the two groups was 2.7 h (95% CI: -8.5 to 3.1 h; p=0.36). At 1 h post-surgery, 65/83 patients (78%) in the pACB group and 32/79 patients (40%) in the FNB group successfully performed the SLR (p<0.0001). Other outcomes were not significantly different between groups.

Results date posted

2020 Year 04 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Eligible patients were scheduled to undergo primary unilateral TKAs from March 2017 to January 2018. They had to be >20 years old and had to fulfill the American Society of Anesthesiologists 1-3 classification. Exclusion criteria included undesignated implant usage, undesignated surgical procedure, concurrent bilateral TKA, revision TKA, allergy to any drugs used in this trial, chronic opioid use, neuromuscular deficits, any infections, and any contraindications to a peripheral nerve block.
Among 182 subjects assessed for eligibility, 179 met the trial criteria. Included patients were preoperatively randomized to either the FNB or the pACB group. Randomization was performed with a computer-generated random number sequence (block size = 4), and groups were stratified by gender.

Participant flow

This trial was approved by the Institutional Review Board (No.2017-016). All patients provided written informed consent. The study was registered at the national registry (UMIN26045), and was conducted in accordance with the principles of the Helsinki Declaration. Data are presented according to the CONSORT statement.

Adverse events

None

Outcome measures

This trial was approved by the Institutional Review Board (No.2017-016). All patients provided written informed consent. The study was registered at the national registry (UMIN26045), and was conducted in accordance with the principles of the Helsinki Declaration. Data are presented according to the CONSORT statement.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 10 Day

Date of IRB

2017 Year 02 Month 01 Day

Anticipated trial start date

2017 Year 02 Month 08 Day

Last follow-up date

2018 Year 06 Month 30 Day

Date of closure to data entry

2018 Year 06 Month 30 Day

Date trial data considered complete

2018 Year 06 Month 30 Day

Date analysis concluded

2018 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2017 Year 02 Month 08 Day

Last modified on

2020 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029932


Research Plan
Registered date File name
2020/11/03 Protocol_merged.pdf

Research case data specifications
Registered date File name
2020/04/23 Data_Sheet.pdf

Research case data
Registered date File name
2020/04/23 Raw_Data.pdf